REFERENCES
- Weyand CM, Hicok KC, Conn DL et al., The influence of HLA-DRBI genes on disease severity in rheumatoid arthritis, Ann Intern Med 117, 801–806 (1992).
- Deighton CM, Walker DJ, Griffiths ID et ai, The contribution of HLA to rheumatoid arthritis, Clin Genet 36, 178–182 (1989).
- Hasstedt S J, Clegg DO, Ingles L et al, HLA-linked rheumatoid arthritis, Am J Hum Genet 55, 738–746(1994).
- Weyand CM, McCarthy IG, Goronzy JJ, Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis, J Clin Invest 95, 2120–2126 (1995).
- Ploski R, Mellbye OJ, Ronningen KS et al., Sero-negative and weakly sero-positive rheumatoid arthritis differ from clearly sero-positive rheumatoid arthritis in HLA class II associations, J Rheumatol 21, 1397–1402 (1994).
- Hassfeld W, Steiner G, Hartmuth K et al. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis, Arthritis Rheum 32, 1515–1520 (1989).
- Young BJ, Mallya RK, Leslie RD, Anti-keratin antibodies in rheumatoid arthritis, BMJ 2,97-99 (1979).
- Mei SE, Jiang M, Wang HZ et al, Antiperinuclear factor in the diagnosis of rheumatoid arthritis, Chinese Med 75, 507 (1995).
- Arnett FC, Edworthy SM, Bloch DA et al, The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum 31, 315–324 (1988).
- Pinais RS, Masi AT, Larsen RA, Preliminary criteria for clinical remission in rheumatoid arthritis, Arthritis Rheum 24, 1308–1315 (1981).
- Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 111, 680–685 (1970).
- Towbin H, Staehelin T, Gordon J, Electrophoretic transfer of proteins from polyacrylamide gels into nitrocellulose sheets: procedure and some application, Proc Natl Acad Sci USA 76, 4350–4354(1979).
- Simon M, Girbal E, Sebbag M et al, The cytokeratin filament aggregating protein filaggrin is the target of the so-called ‘anti-keratin antibodies’, autoantibodies specific for rheumatoid arthritis, J Clin Invest 92, 1387–1393 (1993).
- Kurki P, Aho K, Palosuo T et al, Immunopathology of rheumatoid arthritis. Antikeratin antibodies preceeds the clinical disease, Arthritis Rheum 35, 914 (1992).
- Paimela L, Gripenberg M, Kurki P et al, Antikeratin antibodies: diagnostic and prognostic marks for early rheumatoid arthritis, Ann Rheum Dis 51, 743–746 (1992).
- Vincent C, Serre G, Lapeyre F et ai. High diagnostic value in rheumatoid arthritis of antibodies to the stratum of rat oesophagus epithelium, so-called ‘antikeratin antibodies’, Ann Rheum Dis 48, 712–722 (1989).
- Hajiroussou NJ, Sebbag M et al, Significance of anti-keratin antibodies in rheumatoid arthritis, J Rheumatol 12, 57–63 (1985).
- Kurki P, Aho K, Kaarala K et al, Anti-keratin antibodies (AKA) defines a subset of seropositive erosive polyarthritis, Scand J Rheumatol 21 (suppl.), abstr. 137: 8 (1992),
- Nienhuis RLE, Mandema E, Smids CA, A new serum factor in patients with rheumatoid arthritis: the anti-perinuclear factor, Ann Rheum Dis 23, 302–310 (1964).
- Marmont AM, Damasio EE, Bertorello C et al, Studies on the antiperinuclear factor, Ann Rheum DislO, 117–123(1967).
- Westgeest AA, Boerbooms AM, Jongmans M et al, Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis, J Rheumatol 14, 893–897 (1987).
- Aho K, von Essen R, Kurki P et al, Antikeratin antibodies and antiperinuclear factor as markers for subclinical rheumatoid disease process, J Rheumatol 20, 1278–1281 (1993).